Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial patterns with severe perfusion abnormalities in symptomatic chronic coronary artery disease

Circulation

Volumn 102, Issue 14, 2000, Pages 1605-1610

  Udelson, James E ^a,g   Dilsizian, Vasken ^b   Laham, Roger J ^c   Chronos, Nicolas ^d   Vansant, John ^e   Blais, Michel ^e   Galt, James R ^e   Pike, Marilyn ^f   Yoshizawa, Carl ^f   Simons, Michael ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Atlanta Cardiology Group   (United States)

^e EMORY UNIVERSITY HOSPITAL   (United States)

^f NOVARTIS PHARMA AG   (Switzerland)

^g TUFTS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Growth substances; Heart diseases

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; RECOMBINANT FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DOSE RESPONSE; EXERCISE TEST; HEART MUSCLE PERFUSION; HUMAN; IMAGE ANALYSIS; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIGRAPHY;

EID: 0034601738     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.14.1605     Document Type: Article

References (31)

1. Angiogenic therapy of the human heart
2. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
3. Therapeutic angiogenesis in myocardial ischemia
4. Fibroblast growth factors: At the heart of angiogenesis
5. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor
6. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium
7. Reduction in myocardial infarct size by basic fibroblast growth factor after temporary coronary occlusion in a canine model
8. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model
9. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart
10. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation
11. Intracoronary basic flbroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase 1 open label dose escalation study
12. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT
13. Separate acquisition rest thallium-201/stress technetium-99 m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: A clinical validation study
14. Influence of exercise intensity on the presence, distribution, and size of thallium-201 defects
15. Comparison of 201T1 scintigraphy and low-dose dobutamine echocardiography for the noninvasive assessment of myocardial viability
16. Identification of viable myocardium
17. Concordance and discordance between stress-redistribution-reinjection and restredistribution thallium imaging for assessing viable myocardium: Comparison with metabolic activity by PET
18. Predicting recovery of severe regional ventricular dysfunction: Comparison of resting scintigraphy with thallium 201 and technetium 99 m-sestamibi
19. Modulation of myocardial perfusion and vascular reactivity by pericardial basic fibroblast growth factor: Insight into ischemia-induced reduction in endothelium-dependent vasodilatation
20. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia
21. The stimulation of neo-angiogenesis in the ischemic heart by the human growth factor FGF
22. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts
23. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
24. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
25. Induction of neoangiogenesis in ischemic myocardium by human growth factors
26. Effect of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) on myocardial perfusion: Evidence for a dose-dependent effect
27. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial
28. Collateral vessel growth in the human heart: Role of fibroblast growth factor-2
29. Radiopharmaceuticals in nuclear cardiology
30. Coronary collateral function during exercise
31. Assessment of jeopardized myocardiurn in patients with one-vessel disease